Ursolic acid increases energy expenditure through enhancing free fatty acid uptake and β-oxidation via an UCP3/AMPK-dependent pathway in skeletal muscle

Mol Nutr Food Res. 2015 Aug;59(8):1491-503. doi: 10.1002/mnfr.201400670. Epub 2015 May 28.

Abstract

Scope: Ursolic acid (UA) is a triterpenoid compound with multifold biological functions. Our previous studies have reported that UA protects against high-fat diet-induced obesity and improves insulin resistance (IR). However, the potential mechanisms are still undefined. Free fatty acid (FFA) metabolism in skeletal muscle plays a central role in obesity and IR. Therefore, in this study, we investigated the effect and the potential mechanisms of UA on skeletal muscle FFA metabolism.

Methods and results: In diet-induced obese rats, 0.5% UA supplementation for 6 weeks markedly reduced body weight, increased energy expenditure, decreased FFA level in serum and skeletal muscle and triglyceride content in skeletal muscle. In vitro, the data provided directly evidence that UA significantly increased fluorescently labeled FFA uptake and (3) H-labeled palmitic acid β-oxidation. UA-activated AMP-activated protein kinase (AMPK) and downstream targets were involved in the increase of FFA catabolism. Moreover, upregulated uncoupling protein 3 (UCP3) by UA contributed to AMPK activation via elevating adenosine monophosphate/adenosine triphosphate ratio.

Conclusion: UA increases FFA burning through enhancing skeletal muscle FFA uptake and β-oxidation via an UCP3/AMPK-dependent pathway, which provides a novel perspective on the biological function of UA against obesity and IR.

Keywords: AMP-activated protein kinase; Fatty acid β-oxidation; Free fatty acid uptake; Uncoupling protein 3; Ursolic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism
  • Absorption, Physiological
  • Animals
  • Anti-Obesity Agents / therapeutic use*
  • Cell Line
  • Diet, High-Fat / adverse effects
  • Dietary Supplements*
  • Energy Metabolism*
  • Fatty Acids, Nonesterified / blood
  • Fatty Acids, Nonesterified / metabolism*
  • Ion Channels / agonists*
  • Ion Channels / antagonists & inhibitors
  • Ion Channels / genetics
  • Ion Channels / metabolism
  • Male
  • Mice
  • Mitochondrial Proteins / agonists*
  • Mitochondrial Proteins / antagonists & inhibitors
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism
  • Muscle, Skeletal / enzymology
  • Muscle, Skeletal / metabolism*
  • Obesity / blood
  • Obesity / diet therapy
  • Obesity / etiology
  • Obesity / metabolism
  • RNA Interference
  • Random Allocation
  • Rats, Sprague-Dawley
  • Second Messenger Systems
  • Specific Pathogen-Free Organisms
  • Triterpenes / therapeutic use*
  • Uncoupling Protein 3
  • Ursolic Acid

Substances

  • Anti-Obesity Agents
  • Fatty Acids, Nonesterified
  • Ion Channels
  • Mitochondrial Proteins
  • Triterpenes
  • Ucp3 protein, mouse
  • Ucp3 protein, rat
  • Uncoupling Protein 3
  • AMP-Activated Protein Kinases
  • Prkaa1 protein, rat